NDC 49702-253

Cabenuva

Cabotegravir And Rilpivirine

Cabenuva is a Kit in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is .

Product ID49702-253_0eb2c285-5f70-408e-b710-10888edb2c4e
NDC49702-253
Product TypeHuman Prescription Drug
Proprietary NameCabenuva
Generic NameCabotegravir And Rilpivirine
Dosage FormKit
Marketing Start Date2021-01-21
Marketing CategoryNDA / NDA
Application NumberNDA212888
Labeler NameViiV Healthcare Company
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 49702-253-15

1 KIT in 1 CARTON (49702-253-15) * 2 mL in 1 VIAL (49702-245-01) * 2 mL in 1 VIAL (49702-249-02)
Marketing Start Date2021-01-21
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cabenuva" or generic name "Cabotegravir And Rilpivirine"

NDCBrand NameGeneric Name
49702-240Cabenuvacabotegravir and rilpivirine
49702-253Cabenuvacabotegravir and rilpivirine

Trademark Results [Cabenuva]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CABENUVA
CABENUVA
87420884 5335232 Live/Registered
ViiV Healthcare UK (No.3) Limited
2017-04-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.